Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Bellerophon Therapeutics stock (BLPH)

Buy Bellerophon Therapeutics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Bellerophon Therapeutics is a biotechnology business based in the US. Bellerophon Therapeutics shares (BLPH) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.04 – the same closing value as a week prior. Bellerophon Therapeutics employs 18 staff and has a trailing 12-month revenue of around $5.6 million.

Our top picks for where to buy Bellerophon Therapeutics stock

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Complimentary access to a financial planner

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, and options with as little as $1
  • After-hours trading available
  • Earn 4.5% interest on uninvested cash with Gold
  • 24/7 customer support

How to buy Bellerophon Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BLPH. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Bellerophon Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
OPTO
Finder Score: 3.8 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
SoFi Invest®
Finder Score: 4.3 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
Robinhood
Finder Score: 4.6 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
Uphold
Finder Score: 3.6 / 5: ★★★★★
Crypto alternative
Uphold
★★★★★
Cryptocurrency
N/A
$0
4.65%
Get $10
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Public.com
Finder Score: 4.4 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Bellerophon Therapeutics stock price (PINK: BLPH)

Use our graph to track the performance of BLPH stocks over time.

Bellerophon Therapeutics shares at a glance

Information last updated 2024-12-05.
Latest market close$0.04
52-week range$0.03 - $0.08
50-day moving average $0.04
200-day moving average $0.05
Wall St. target price$2.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.89

Bellerophon Therapeutics price performance over time

Historical closes compared with the close of $0.04 from 2024-12-05

1 week (2024-11-29) 0.04
1 month (2024-11-07) 8.11%
3 months (2024-09-06) 14.29%
6 months (2024-06-07) -46.60%
1 year (2023-12-07) 10.50%
2 years (2022-12-07) -95.88%
3 years (2021-12-07) 2.57
5 years (2019-12-06) 6.2265

Bellerophon Therapeutics financials

Revenue TTM $5.6 million
Gross profit TTM $0
Return on assets TTM -78.47%
Return on equity TTM -165.96%
Profit margin -164.06%
Book value $0.30
Market Capitalization $489,304

TTM: trailing 12 months

Bellerophon Therapeutics share dividends

We're not expecting Bellerophon Therapeutics to pay a dividend over the next 12 months.

Have Bellerophon Therapeutics's shares ever split?

Bellerophon Therapeutics's shares were split on a 1:15 basis on 9 February 2020 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bellerophon Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Bellerophon Therapeutics shares which in turn could have impacted Bellerophon Therapeutics's share price.

Bellerophon Therapeutics share price volatility

Over the last 12 months, Bellerophon Therapeutics's shares have ranged in value from as little as $0.03 up to $0.0785. A popular way to gauge a stock's volatility is its "beta".

BLPH.US volatility(beta: 0.7)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Bellerophon Therapeutics's is 0.704. This would suggest that Bellerophon Therapeutics's shares are less volatile than average (for this exchange).

Bellerophon Therapeutics overview

Bellerophon Therapeutics, Inc. , a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse, which is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc.

Frequently asked questions

null
What percentage of Bellerophon Therapeutics is owned by insiders or institutions?
Currently 15.027% of Bellerophon Therapeutics shares are held by insiders and 8.394% by institutions.
How many people work for Bellerophon Therapeutics?
Latest data suggests 18 work at Bellerophon Therapeutics.
When does the fiscal year end for Bellerophon Therapeutics?
Bellerophon Therapeutics's fiscal year ends in December.
Where is Bellerophon Therapeutics based?
Bellerophon Therapeutics's address is: 20 Independence Boulevard, Warren, NJ, United States, 07059
What is Bellerophon Therapeutics's ISIN number?
Bellerophon Therapeutics's international securities identification number is: US0787713009
What is Bellerophon Therapeutics's CUSIP number?
Bellerophon Therapeutics's Committee on Uniform Securities Identification Procedures number is: 078771300

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site